Titan Pharmaceuticals
TTNP
#10565
Rank
โ‚น0.58 B
Marketcap
โ‚น438.96
Share price
-3.76%
Change (1 day)
29.84%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น418.02. In 2023 the company made an earnings per share (EPS) of -โ‚น705.58 an increase over its 2022 EPS that were of -โ‚น1,446.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น705.58-51.22%
2022-โ‚น1,446-15.61%
2021-โ‚น1,714-81.37%
2020-โ‚น9,198-77.52%
2019-โ‚น40,926-56.32%
2018-โ‚น93,697-59.51%
2017-โ‚น2,31,433-371.81%
2016โ‚น85,144-144.35%
2015-โ‚น1,91,965300%
2014-โ‚น47,991-121.54%
2013โ‚น2,22,817-151.38%
2012-โ‚น4,33,636-11.54%
2011-โ‚น4,90,197188.89%
2010-โ‚น1,69,684-10%
2009-โ‚น1,88,537
2007-โ‚น7,73,003-2.38%
2006-โ‚น7,91,857-39.13%
2005-โ‚น13,00,907-16.87%
2004-โ‚น15,64,860-22.43%
2003-โ‚น20,17,3494.9%
2002-โ‚น19,23,08061.9%
2001-โ‚น11,87,785-13.7%
2000-โ‚น13,76,32265.01%
1999-โ‚น8,34,098-35.87%
1998-โ‚น13,00,686-1824.71%
1997โ‚น75,415-102.4%
1996-โ‚น31,48,573

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น831.88-299.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น668.44-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น135.21-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น87.60-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น23.81-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น370.41-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA